RxDoctor Payments Data

Domenico Colletti, PA

Medical · Barnegat, NJNPI 1851805741

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 462 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 25.4% of the total. Among medical clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,416in general payments, 2019–2025

Across 462 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • E.r. Squibb & Sons, L.L.C.$970
  • LEO Pharma Inc.$693
  • Lilly USA, LLC$547
  • Incyte Corporation$502
  • Regeneron Healthcare Solutions, Inc.$405
  • plus $2K from 18 others

What the payments were for

  • Travel & lodging$3485%
  • Food & beverage$6,99094%
  • Education$771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,416 in reported general payments places this provider in the 90th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey

Medicare billing

Part B allowed, 2024
$230,793
Medicare patients
925
Services billed
3,157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab43$155,146
Dupixent PenDupilumab29$118,762
Fluorouracil147$8,896
Clobetasol Propionate101$3,853
Ketoconazole171$3,394
Triamcinolone Acetonide253$3,330
Metronidazole29$1,396
Doxycycline Hyclate50$1,106
Ciclopirox17$421
Mupirocin73$405
Fluocinonide11$319
Ammonium Lactate16$198
Silver Sulfadiazine14$118
Prednisone29$84

Paid to pharmacies, not to this prescriber.

Other medical in Barnegat

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →